Literature DB >> 21252489

Sporadic aneuploidy in PHA-stimulated lymphocytes of trisomies 21, 18, and 13.

O Reish1, M Regev, A Kanesky, S Girafi, M Mashevich.   

Abstract

Following the observation detected in a previous study that X chromosome monosomy in Turner's syndrome genotypes was associated with a sporadic loss and/or gain of other chromosomes, we studied here whether this instability is a consistent finding in constitutional autosomal trisomies. We used PHA-stimulated lymphocytes derived from 14 patients (10 patients with trisomy 21, 2 with trisomy 18, and 2 with trisomy 13). Fourteen healthy controls were compared. Fluorescence in situ hybridization, applied at interphase cells, was used to evaluate the level of aneuploidy for 3 randomly selected chromosomes (autosomes 8, 15, and 16) in each sample. For each tested chromosome, our results showed a significantly higher level of aneuploid cells in the samples from the patients than in those from controls, with no difference between the patient groups. The mean level of aneuploid cells (percentage) for all 3 tested autosomes was almost twice as high in the patient samples as in the control samples. The aneuploidy level was mainly due to monosomy, which was significantly higher in the samples from the patients than in those from controls for each one of the tested chromosomes, with no difference between the patient groups. The mean level of monosomic cells (percentage) for all 3 tested chromosomes was almost twice as high in the patient samples as in the control samples. Our study shows that various constitutional autosomal trisomies are associated with an increased frequency of non-chromosome specific aneuploidy and is a continuation of the previous study documenting sporadic aneuploidy in Turner's sample cells. It is possible that primary aneuploid cells destabilize their own genome resulting in variable aneuploidy of other chromosomes. It is also possible that one or several common factor(s) is/are involved in both constitutional and sporadic aneuploidy.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252489     DOI: 10.1159/000323504

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  12 in total

1.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

2.  Does aneuploidy destabilize karyotypes automatically?

Authors:  Peter H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-25       Impact factor: 11.205

3.  Whole chromosome gain does not in itself confer cancer-like chromosomal instability.

Authors:  Anders Valind; Yuesheng Jin; Bo Baldetorp; David Gisselsson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

Review 4.  Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos.

Authors:  Tamara A Potapova; Jin Zhu; Rong Li
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 5.  Aneuploidy in health, disease, and aging.

Authors:  Robin M Ricke; Jan M van Deursen
Journal:  J Cell Biol       Date:  2013-04-01       Impact factor: 10.539

6.  Aneuploidy and chromosomal instability in cancer: a jackpot to chaos.

Authors:  Maybelline Giam; Giulia Rancati
Journal:  Cell Div       Date:  2015-05-20       Impact factor: 5.130

7.  Chromosome mis-segregation and cytokinesis failure in trisomic human cells.

Authors:  Joshua M Nicholson; Joana C Macedo; Aaron J Mattingly; Darawalee Wangsa; Jordi Camps; Vera Lima; Ana M Gomes; Sofia Dória; Thomas Ried; Elsa Logarinho; Daniela Cimini
Journal:  Elife       Date:  2015-05-05       Impact factor: 8.140

8.  Cancer karyotypes: survival of the fittest.

Authors:  Joshua M Nicholson; Daniela Cimini
Journal:  Front Oncol       Date:  2013-06-07       Impact factor: 6.244

Review 9.  Multi-layered cancer chromosomal instability phenotype.

Authors:  Anna V Roschke; Ester Rozenblum
Journal:  Front Oncol       Date:  2013-12-11       Impact factor: 6.244

10.  Selective advantage of trisomic human cells cultured in non-standard conditions.

Authors:  Samuel D Rutledge; Temple A Douglas; Joshua M Nicholson; Maria Vila-Casadesús; Courtney L Kantzler; Darawalee Wangsa; Monika Barroso-Vilares; Shiv D Kale; Elsa Logarinho; Daniela Cimini
Journal:  Sci Rep       Date:  2016-03-09       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.